RGCON 2020 Focussed on Hemato-Oncology Update

▴ RGCON 2020
RGCON is focused on an all-important aspect of Hemato-oncology Update. Haematology-oncology includes such diseases as Leukaemia, Lymphoma, Myeloma, Iron Deficiency Anaemia, Haemophilia, etc.

RGCON 2020, the 19th Annual International Conference of Rajiv Gandhi Cancer Institute and Research Centre to be held in New Delhi from 7th - 9th February 2020 is focused on an all-important aspect of Hemato-oncology Update. Haematology-oncology includes such diseases as Leukaemia, Lymphoma, Myeloma, Iron Deficiency Anaemia, Haemophilia, Sickle Cell Disease, Thalassemia as well as cancers of other organs.

“Renowned national and international experts in the field of Haematology, Hemato-oncology & Stem Cell Transplant have committed their participation to share their views & deliver lectures on the current practices. As a distinctive feature, RGCON 2020 will cover latest updates from American Society of Haematology (ASH) and American Society of Clinical Oncology (ASCO) and various other events,” said Dr. Dinesh Bhurani, Director, Department of Hemato-Oncology & Bone Marrow Transplant, RGCIRC & Organising Secretary – RGCON 2020.

“Over the years, the aim of RGCON has been to bring eminent international and national faculty at one platform to share new advances in oncology and haematology leading to good interaction between faculty and delegates. We are fortunate to have distinguished international and national faculty for RGCON 2020 too,” said Dr. Sudhir Kumar Rawal, Medical Director and Chief of GenitoUro – Oncology Services RGCIRC.

Another unique feature of RGCON 2020 is a get together of Myeloma patients. The First Myeloma patient who got CarT cell treatment from China will also be present & share her experience.

Over the years, Hemato-Oncology has witnessed some path breaking advancements. Blood Cancers are treated with chemotherapy while some require bone marrow transplant. Now Targeted Therapy and Immunotherapy are fast taking the place of chemotherapy in treatment of blood cancers. Under immunotherapy, body’s own T cells are modified to kill cancer cells, added Dr. Bhurani.

Blood cancers account for around 20% of the total cancers in India. Different blood cancers occur at different age groups. Leukaemia occurs in Children while Lymphoma and Myeloma generally occur in old age.

Speaking about causes of blood cancers, Dr. Bhurani stated, blood cancers generally don’t have any direct causal relationship. Blood cancers are due to genetic changes in cells and generally not linked to any preventive causes.

The symptoms of blood cancers include fever and bleeding from any part – nose, mouth etc in case of leukaemia and lumps in neck in case of Lymphoma.

Tags : #Rgcon #Bloodcancer #Stemcell #Transplant #Hematooncology #Medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023
Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023